Communicable disease threats report, 14-20 February 2016, week 7
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 February 2016 and includes updates on Zika virus, MERS and seasonal influenza.
Public Consultation: Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza
A consultation with European and international public health experts was convened to review data presented in newly conducted systematic reviews and meta-analyses regarding influenza antivirals, in order to develop an ECDC Expert Opinion.
EU Laboratory Capability Monitoring System (EULabCap) - Report on 2013 survey of EU/EEA country capabilities and capacities
The ECDC public health microbiology strategy (2012–2016) aims to strengthen the capability and capacity of the EU public health microbiology system to provide the timely and reliable information that underpins infectious threat detection, assessment and surveillance at Member State and EU level for effective prevention and control of infectious diseases.
Communicable disease threats report, 7-13 February 2016, week 6
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 February 2016 and includes updates on Zika virus, Ebola virus disease and seasonal influenza.
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014
The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014, covers resistance in zoonotic Salmonella and Campylobacter species from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food.
Risk Assessment: Seasonal influenza 2015–2016 in the EU/EEA countries
This risk assessment summarises the development of the 2015–16 influenza season, which so far has been characterised by a prevalence of type A viruses.
Assessing communicable disease control and prevention in EU enlargement countries
This technical document presents a package of tools for the assessment of public health capacities of enlargement countries (EU Candidate Countries and EU Potential Candidate Countries) in the area of communicable disease prevention and control. ECDC has been working with enlargement countries since 2006 in order to strengthen their capacities to implement EU legislation, fulfil the necessary requirements, and meet a core set of accession criteria in this field.
Communicable disease threats report, 31 January - February 2016, week 5
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 January - 6 February 2016 and includes updates on Zika virus, Ebola virus disease and seasonal influenza.
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- Middle East respiratory syndrome coronavirus
- migrant health
- public health threat
- United States
- Vaccine Preventable Diseases Programme
- Western Africa
- Zika virus infection
- Zika virus infection - Outbreak in the Americas
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 1st update, 3 February 2016
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Salmonellosis - Annual Epidemiological Report 2016 [2014 data]
In 2014, 91 408 salmonellosis cases were reported by 30 EU/EEA countries, with 89 883 confirmed cases and an EU/EEA notification rate of 25.4 cases per 100 000 population.